Jiahao T. Liu
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Naja atra SVPLA2 contributes to venom-induced AKI via HRAS palmitoylation-dependent PI3K-AKT inactivation.
Journal: Journal of lipid research
Published: June 19, 2026
Naja atra SVPLA2 upregulates hexokinase 2-driven macrophage M1 polarization via the cGAS-STING signaling activation.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: June 08, 2026
Non-targeted metabolomics reveals the metabolic atlas of macrophages remodeled by SVPLA2 in Naja atra venom.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: May 26, 2026
Meloxicam Alleviates Sepsis-Induced Lung Injury by Inhibiting Pyroptosis Through CBP/TXNIP/p38 Signaling Pathway.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 10, 2026
Naja atra SVPLA2 Aggravates Acute Kidney Injury Through Metabolic Reprogramming-Dependent Macrophage Polarization and Defective Efferocytosis.
Journal: Toxins
Published: February 10, 2026
Chinese cobra (Naja atra) SVPLA2 promotes muscle inflammation via RPL35A-mediated translational reprogramming.
Journal: Communications biology
Published: September 04, 2025
An integrated single-nucleus ribonucleic acid sequencing and spatial transcriptomic atlas reveals stage-specific neuronal and glial trajectories in a mouse model of amyotrophic lateral sclerosis.
Journal: Neural regeneration research
Published: June 12, 2025
Varespladib attenuates Naja atra-induced acute liver injury via reversing Nrf2 signaling-mediated ferroptosis and mitochondrial dysfunction.
Journal: Redox report : communications in free radical research
Published: May 21, 2025
Revealing the key organelle in the pathophysiology and clinical applications of animal toxins: Mitochondria.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: January 12, 2025
Exploring COX-Independent Pathways: A Novel Approach for Meloxicam and Other NSAIDs in Cancer and Cardiovascular Disease Treatment.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 06, 2024
Last Updated: 09/26/2026